by Administrateur Biofortis | Dec 22, 2022 | Health
Killing tumour cells by fatty indigestion: here is the strategy to fight cancer, explored by Belgian scientists from Louvain University. Their work, recently published in Cell Metabolism(1), provided many convincing arguments from in vitro and animal experiments. Not...
by Administrateur Biofortis | Nov 9, 2022 | News
We are pleased to welcome Morgan Cabigliera, as Head of the Sales & Marketing Business Unit and Fanny Doistau, as Clinical Business Unit Director, as part of the Biofortis team. Morgan has a dual background in molecular biology and business. He has more than 20...
by Administrateur Biofortis | Nov 2, 2022 | Microbiome
It is quite well-known nowadays that our body cavities such as the gut, mouth, nose, lungs, vagina, or our skin surface, shelter millions of micro-organisms: these communities are called microbiomes. In recent years, more confidential microbiomes have been described:...
by Administrateur Biofortis | Sep 15, 2022 | News
Read the press release Biofortis as a unique full service CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science for Human and Animal Health is part of Le French Gut project. Le French Gut project National contribution to collect 100,000...
by Administrateur Biofortis | Jun 28, 2022 | Microbiome
IBS is a 3-letter acronym that strongly impacts the lives of millions of people worldwide. It stands for irritable bowel syndrome, a complex condition that exhibits various forms, depending on the predominant stool pattern: diarrhea, constipation, mixed or...